(Press-News.org) Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
Scientists at the Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID) and Wellcome Sanger Institute showed that following SARS-CoV-2 infection, cells in the lining of the lungs, nasal cells, and immune cells in the blood show a blunted inflammatory response in obese patients, producing suboptimal levels of molecules needed to fight the infection.
Since the start of the pandemic, there have been almost 760 million confirmed cases of SARS-CoV-2 infection, with almost 6.9 million deaths. While some people have very mild – or even no – symptoms, others have much more severe symptoms, including acute respiratory distress syndrome requiring ventilator support.
One of the major risk factors for severe COVID-19 is obesity, which is defined as a body mass index (BMI) of over 30. More than 40% of US adults and 28% of adults in England are classed as obese.
While this link has been shown in numerous epidemiological studies, until now, it has not been clear why obesity should increase an individual’s risk of severe COVID-19. One possible explanation was thought to be that obesity is linked to inflammation: studies have shown that people who are obese already have higher levels of key molecules associated with inflammation in their blood. Could an overactive inflammatory response explain the connection?
Professor Menna Clatworthy is a clinician scientist at the University of Cambridge, studying tissue immune cells at CITIID alongside caring for patients at Addenbrooke’s Hospital, part of Cambridge University Hospitals NHS Foundation Trust. She said: “During the pandemic, the majority of younger patients I saw on the COVID wards were obese. Given what we know about obesity, if you’d asked me why this was the case, I would have said that it was most likely due to excessive inflammation. What we found was the absolute opposite.”
Clatworthy and her team analysed blood and lung samples taken from 13 obese patients with severe COVID-19 requiring mechanical ventilation and intensive care treatment, and 20 controls (non-obese COVID-19 patients and ventilated non-COVID-19 patients). These included patients admitted to the Intensive Care Unit at Addenbrooke’s Hospital.
Her team used a technique known as transcriptomics, which looks at RNA molecules produced by our DNA, to study activity of cells in these key tissues. Their results are published in the American Journal of Respiratory and Critical Care Medicine.
Contrary to expectations, the researchers found that the obese patients had underactive immune and inflammatory responses in their lungs. In particular, when compared to non-obese patients, cells in the lining of their lungs and some of their immune cells had lower levels of activity among genes responsible for the production of two molecules known as interferons (INF) – interferon-alpha and interferon-gamma – which help control the response of the immune system, and of tumour necrosis factor (TNF), which causes inflammation.
When they looked at immune cells in the blood of 42 adults from an independent cohort, they found a similar, but less marked, reduction in the activity of interferon-producing genes as well as lower levels of IFN-alpha in the blood.
Professor Clatworthy said: “This was really surprising and unexpected. Across every cell type we looked at, we found that that the genes responsible for the classical antiviral response were less active. They were completely muted.”
The team was able to replicate its findings in nasal immune cells taken from obese children with COVID-19, where they again found lower levels of activity among the genes that produce IFN-alpha and IFN-gamma. This is important because the nose is one of the entry points for the virus – a robust immune response there could prevent the infection spreading further into the body, while a poorer response would be less effective.
One possible explanation for the finding involves leptin, a hormone produced in fat cells that controls appetite. Leptin also plays a role in the immune response: in individuals who are normal weight, levels of the hormone increase in response to infection and it directly stimulates immune cells. But obese people already have chronically higher levels of leptin, and Clatworthy says it is possible that they no longer produce sufficient additional leptin in response to infection, or are insensitive to it, leading to inadequate stimulation of their immune cells.
The findings could have important implications both for the treatment of COVID-19 and in the design of clinical trials to test new treatments.
Because an overactive immune and inflammatory response can be associated with severe COVID-19 in some patients, doctors have turned to anti-inflammatory drugs to dampen this response. But anti-inflammatory drugs may not be appropriate for obese patients.
Co-author Dr Andrew Conway Morris from the Department of Medicine at the University of Cambridge and Honorary Consultant on the intensive care unit at Addenbrooke’s Hospital said: “What we’ve shown is that not all patients are the same, so we might need to tailor treatments. Obese subjects might need less anti-inflammatory treatments and potentially more help for their immune system.”
Clinical trials for potential new treatments would need to involve stratifying patients rather than including both severe and normal weight patients, whose immune responses differ.
The research was largely supported by Wellcome, the Medical Research Council and the National Institute of Health Research, including via the NIHR Cambridge Biomedical Research Centre.
Reference
Guo, SA, Bowyer, GS, Ferdinand, JR, Maes, M & Tuong, ZK et al. Obesity associated with attenuated tissue immune cell responses in COVID-19. Am J Resp Critical Care Med; 1 Mar 2023; DOI: 10.1164/rccm.202204-0751OC
END
Underactive immune response may explain obesity link to COVID-19 severity
2023-03-20
ELSE PRESS RELEASES FROM THIS DATE:
Unrealistic vaping views? Nearly ½ of parents confident they’d know if their child vapes
2023-03-20
Nearly half of parents say they would definitely know if their child was vaping, despite characteristics of vaping devices that make it easy to hide or disguise their use, a new national poll suggests.
Four in five parents also think their adolescent or teen understands the health risks of vaping with few believing their child has tried it, according to the C.S. Mott Children’s Hospital National Poll on Children’s Health at University of Michigan Health.
“Very few parents believe their ...
Changing one’s behavior in different social interactions is child's play
2023-03-20
Society and social interaction play a key role in life for humans. The well-being of a person greatly depends upon their ability to be part of complex socio-cultural institutions. Even during infancy, humans rely on their social interactions with other humans for social and cultural learning, subsequent adaptation to different social environments, and ultimately, survival. Several studies have shown that infants do not respond automatically or reflexively to external cues, but instead adaptively modulate their social behaviors to suit their social context. Gaze-following is one such behavior that infants modulate based on their surroundings. ...
Financial landlords own four times more rental units than previously thought
2023-03-20
New research indicates that a small percentage of financial landlords, like private equity firms and institutional investors, own four times more of Montreal’s rental housing stock than was previously estimated. Neighbourhoods with more financial landlords are also experiencing higher housing stress levels.
In the first comprehensive analysis of its kind in a North American city, researchers from the University of Waterloo and McGill University developed a new method of identifying networks of property ownership lurking behind ...
Multi-drug resistant organisms can be transmitted between healthy dogs and cats and their hospitalised owners
2023-03-19
**Note: the release below is a special early release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story**
Embargo: 2301H UK time Saturday 18 March
Healthy dogs and cats could be passing on multidrug-resistant organisms (MDROs; bacteria that resist treatment with more than one antibiotic) to their hospitalised owners, and likewise humans could be transmitting these dangerous microbes to their pets, according to new research being presented ...
New immunotherapy strategies in targeting complexity in the tumor microenvironment
2023-03-18
Alexandria, VA – A symposium aiming to provide a better understanding of the tumor microenvironment, immune tolerogenic niches at cancer initiation, and novel immunotherapeutic strategies in head and neck cancer patients was featured at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR. The AADOCR/CADR Annual Meeting & Exhibition took place at the Oregon Convention Center in Portland on March 15-18, 2023.
Cancer ...
Towards a greater degree of diversity, equity, and inclusion in the oral health space
2023-03-18
Alexandria, VA – In alignment with AADOCR’s Diversity and Inclusion Statement, several symposia exploring the ongoing challenges in addressing the oral health care needs of equity-deserving populations were featured at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR. The AADOCR/CADR Annual Meeting & Exhibition took place at the Oregon Convention Center in Portland on March 15-18, 2023.
The symposium, “Assessing Oral Health ...
Study outlines the development of a novel adhesive patch capable of treating oral lichen planus and recurrent aphthous stomatitis
2023-03-18
Alexandria, VA – A study exploring the development of “Dental Tough Adhesive (DenTAI)”, a novel bioinspired adhesive patch with robust mechanical properties, capable of strong adhesion, and able to carry out extended release of clobetasol-17-propionate, the first-line drug for treating oral lichen planus (OLP) and recurrent aphthous stomatitis (RAS) was presented at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual ...
Towards a better understanding of the structural and functional properties of salivary mucins
2023-03-18
Alexandria, VA – A symposium exploring the significance, interactions, and evolutionary mechanisms of salivary mucins was featured at the 52nd Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 47th Annual Meeting of the CADR. The AADOCR/CADR Annual Meeting & Exhibition took place at the Oregon Convention Center in Portland on March 15-18, 2023.
Mucin proteins in saliva are responsible for the unique physicochemical properties of saliva that include lubrication, viscosity, and barrier function. A dense array of O-glycans attached to the mucin protein backbone provide mucins with their typical functions.
Recently, ...
Can ChatGPT be counted on?
2023-03-18
A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they become popular resources for cancer information. They found these resources give accurate information when asked about common cancer myths and misconceptions. In the first study of its kind, Skyler Johnson, MD, physician-scientist at Huntsman Cancer Institute and assistant professor in the department of radiation oncology at the University of Utah (the U), evaluated the reliability and accuracy of ChatGPT’s ...
Step forward in gene therapy to treat cause of sudden cardiac arrest in athletes
2023-03-18
University of Utah Health scientists have corrected abnormal heart rhythms in mice by restoring healthy levels of a protein that heart cells need to establish connections with one another. That protein, GJA1-20k, is underproduced in people with a genetic condition called arrhythmogenic cardiomyopathy, one of the leading causes of sudden cardiac arrest in athletes under the age of 35.
The finding, reported in the journal Circulation Research, suggests a new strategy for treating the abnormal heart rhythms caused by arrhythmogenic cardiomyopathy.
The results may also have implications for treating dangerous arrhythmias associated with more common ...